Additive manufacturing technologies like printing have tremendous potential to change the field of personalized medicine. Special groups of patients like infants often cannot swallow standard medication that is produced in a one-size-fits all manner. 3D-printing and inkjet printing enable rapid and accurate dispensing of drug-containing inks, thus enabling tailored production of personalized medicine with individual doses and a non-traditional format. We now propose the production of individualized medicine by inkjet-printing into porous substrates. Distribution of the drug-ink in porous substrate will be modeled and validated with drug deposition experimental data. This project will demonstrate the feasibility of individual drug dispensing on patient-friendly substrate materials and is a part of the ERC Proof of Concept (PoC) PrintMed project (No. 963914).
Hamed Aslannejad, PhD
10/2021 - 12/2021